/ACCESS / VALUE OF INNOVATION / OBJECTIVES

ACCESS / VALUE OF INNOVATION

POLICY PAPERS OBJECTIVES ACTIVITIES

EVENTS

SOCIAL MEDIA

TWITTER

OBJECTIVES

  • Making innovative PM technology more accessible in the European Union 
  • Patients are at the centre of the health care process and should be more actively involved in the Health Technology Assessments (HTA)
  • Adapting HTA to the new paradigm of personalised medicine
  • Prices that reflect a different value in different indications
  • Coordination assessment and reimbursement mechanisms for drugs and diagnostics
  • Post-launch value assessments: addressing uncertainty where it matters most
  • EU Member States should establish efficient data collection infrastructure to monitor utilisation, effectiveness and other quality of care in considerations of PM technology and services under routine care conditions.
  • Effectives forms of utilisation management to address the inherent complexity of PM technologies and services

SOCIAL MEDIA